Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,834 total articles
Jefferson Capital, Inc., a leading purchaser and manager of charged-off consumer accounts, will announce its first quarter 2026 financial results after market close on May 14, followed by a webcast to discuss the results. The company operates across the US, Canada, UK, and Latin America, servicing secured and unsecured assets for major creditors an…
DMC Global Inc. reported Q1 2026 financial results reflecting a 15% year-over-year sales decline to $135.6 million and adjusted EBITDA of $3.9 million, down from $14.4 million a year ago, impacted by geopolitical tensions in the Middle East, higher raw material prices, and softer demand in key markets. All business segments—Arcadia Products, DynaEn…
RadNet, Inc. announced a strategic joint venture with Saint Alphonsus Health System in Boise, Idaho, through a majority stake in Intermountain Medical Imaging. The partnership integrates RadNet's outpatient diagnostic imaging expertise and DeepHealth AI technology solutions with Saint Alphonsus's regional healthcare network to improve clinical and …
Cocrystal Pharma presented promising progress on CDI-988, an oral direct-acting antiviral targeting norovirus, at ICAR 2026. The Phase 1b human challenge study is fully enrolled in its initial cohort, aiming to establish proof-of-concept for prevention and treatment. CDI-988 targets a conserved protease region across all norovirus strains and coron…
Strata Critical Medical, Inc. completed the acquisition of Ohio Valley Perfusion Associates, a regional provider of perfusion services in Ohio and Pennsylvania. The acquisition strengthens Strata's clinical platform in these regions, enabling expansion of services like ECMO support and organ recovery. The purchase aligns with Strata's M&A strategy,…
LPL Financial Holdings Inc. announced solid financial results for Q1 2026, highlighting a 19% increase in net income to $356 million and a 9% rise in adjusted EPS to $5.60. The company achieved a 30% year-over-year increase in total client assets to $2.3 trillion, with advisory assets growing 42% to $1.4 trillion. Strategic initiatives including pi…
OrthoPediatrics Corp. reported a 13% increase in Q1 2026 revenue to $59.4 million driven by growth in Trauma & Deformity, Scoliosis, and OPSB product lines. Adjusted EBITDA improved to $2.2 million from a loss last year and free cash flow usage decreased 40%. The company raised its 2026 revenue guidance to $263-267 million, expecting 11-13% growth.…
Stryker Corporation reported a 2.6% increase in net sales to $6.0 billion for Q1 2026, with organic sales rising 2.4%. Reported earnings per share increased 14.2% to $1.93, while adjusted EPS decreased 8.5% to $2.60. The company announced a restructuring combining orthopaedic instruments and other orthopaedics into a new Ortho Tech business to impr…
SPX Technologies, Inc. reported a robust first quarter for 2026 with revenues up 17.4% to $566.8 million and GAAP income increasing 24.6% to $64.4 million. Adjusted EPS rose 22.5% to $1.69. The company raised its full-year 2026 guidance reflecting strong demand, especially in data center solutions, capacity expansions, and contributions from recent…
Elutia Inc., a Nasdaq-listed biotechnology company specializing in drug-eluting biomatrix technologies for medical devices, will report its first quarter 2026 financial results after market close on May 14, 2026. The company’s management will hold a webcast and conference call to discuss the results.
Nyxoah SA announced its participation at the Bank of America 2026 Healthcare Conference where it will present its innovative Genio system, a leadless, battery-free neurostimulation device to treat Obstructive Sleep Apnea (OSA). Nyxoah recently achieved FDA approval for its device in the U.S. and expanded its European CE mark indications, positionin…
Arhaus, Inc., a premium home furnishings company, announced that it will release its first quarter 2026 financial results on May 7, 2026, before the market opens. The company will host a conference call and webcast to discuss the financial and operational results, emphasizing its vertically integrated model and commitment to responsibly sourced, ar…
NMI Holdings, Inc. reported net income of $99.3 million or $1.28 diluted EPS for Q1 2026, reflecting steady financial performance compared to previous quarters. The company saw growth in primary insurance-in-force to $222.3 billion and increased net premiums earned to $154.8 million. Low loss and expense ratios underscore efficient underwriting and…
Brazil Potash Corp. (NYSE American: GRO), advancing the Autazes potash project in Brazil, has announced a proposed underwritten public offering of common shares and pre-funded warrants to raise capital for working capital and general corporate purposes. The offering specifics, including price and size, will be determined based on market conditions.…
Alignment Healthcare, Inc. reported strong Q1 2026 financial results with total revenue of $1.24 billion, a 33.3% increase year-over-year, and Medicare Advantage membership growth of 30.9% to approximately 284,800 members. The company improved profitability, delivering net income of $11.4 million compared to a net loss the prior year, and raised th…
Monolithic Power Systems, Inc. reported record quarterly revenue of $804.2 million for Q1 2026, marking a 7.1% increase over Q4 2025 and a 26.1% rise compared to Q1 2025. The company demonstrated strength in its diversified markets, notably with Communications revenue up 33% sequentially and nearly doubling in Enterprise Data year-over-year. Gross …
Frequency Electronics, Inc. has announced a new minimum revenue target of $150 million by fiscal 2029, reflecting confidence in its expanding backlog and larger end-markets in space and defense technologies. The company anticipates a compound annual growth rate over 30%, driven by advancements in quantum sensing, proliferated satellites, space expl…
Ascendis Pharma, a global biopharmaceutical company, announced it will report Q1 2026 financial results and provide a business update on May 7, 2026. The company will host a conference call and webcast to discuss the results and their TransCon technology platform aimed at developing best-in-class therapies addressing unmet medical needs.
Pacira BioSciences reported a 5% revenue increase in Q1 2026 to $177 million, driven by robust sales growth across its commercial portfolio, including a 7% volume increase for EXPAREL. The company completed enrollment in a Phase 3 study for ZILRETTA targeting shoulder osteoarthritis pain, with topline results expected by year-end. Additional real-w…
Xenon Pharmaceuticals, a neuroscience-focused biopharmaceutical company, announced it will report its Q1 2026 financial results and provide a business update after U.S. market close on May 7, 2026. The company is advancing clinical trials for its lead drug azetukalner and other ion channel modulators targeting epilepsy, depression, and pain.
Ardelyx Inc. reported a 38% year-over-year increase in Q1 2026 total product revenue to $93.4 million, driven primarily by a 58% growth in IBSRELA sales. The company reiterated its 2026 full-year revenue guidance and highlighted progress in clinical development, including Phase 3 trials for IBSRELA in chronic idiopathic constipation and ongoing stu…
OrthoPediatrics Corp. expands its Specialty Bracing portfolio with the introduction of the TRAXIO Complete - Weight System, a mechanical halo gravity traction device designed for pediatric spinal realignment in hospital settings. Developed in collaboration with Synetik Group, the system supports pediatric spine care by offering an adaptable, patien…
Asure Software announced its first quarter 2026 results demonstrating a 23% year-over-year revenue increase to $42.8 million and net income of $0.6 million compared to a prior year net loss. Adjusted EBITDA rose 69% to $12.3 million, reflecting improved profitability and operational efficiency. The company is investing strategically in sales, marke…
Syndax Pharmaceuticals reported a 224% year-over-year increase in total revenue to $64.9 million in Q1 2026 driven by strong sales of Revuforj and Niktimvo. The company highlighted leadership in menin inhibition with revumenib (Revuforj) and continued growth of Niktimvo's collaboration revenue. Syndax anticipates key data releases in 2026 including…
Casella Waste Systems, Inc. released its Q1 2026 financial results showing a 9.6% increase in revenues to $457.3 million, driven by acquisitions and solid waste pricing growth. Adjusted EBITDA increased 12.3% to $97.1 million, and the company raised its full-year 2026 guidance for revenues, Adjusted EBITDA, and Adjusted Free Cash Flow, reflecting c…
